Sedgefield-based detection technology developer Kromek has entered into an agreement with a US-based company to develop the next generation of CT scanners.
The business will work with Analogic Corporation to create Cadmium Zinc Telluride (CZT) based detector products for Photon Counting Computed Tomography (PCCT) applications in the medical imaging and security sectors.
CZT-based PCCT detectors overcome limitations inherent in conventional CT detectors to bring forward improvements in spatial resolution, radiation dose reduction and energy resolution.
The technology could result in improved image quality, while allowing early detection of illnesses such as breast cancer and heart disease.
As part of the collaboration, Kromek will integrate CZT sensors with Analogic's detector designs.
Analogic has worked within CT detector technology for more than 50 years and continues to advance its products in both security and medical imaging applications.
The collaboration follows Kromek unveiling a seven-year medical imaging contract with a Tier 1 OEM.
Arnab Basu, chief executive of Kromek, said: "At Kromek we are constantly looking to team up with leading global organisations who match our vision and desire to improve patient outcomes as well as combine our technologies to enhance the safety of our citizens. Analogic has a long track record in doing just this and we are looking forward to our collaboration to enable Analogic to bring the next generation of CT scanners to the market."
Tom Ripp, Analogic chief executive, added: "As pioneers in CT imaging and detection technology, we are excited about this collaboration with Kromek to bring the next generation of PCCT detection solutions to market.
"This project underscores Analogic's desire to make the world a healthier and safer place for patients and passengers globally."
